Cerba Healthcare
Cerba Healthcare, headquartered in France, is a leading player in the global healthcare sector, specialising in laboratory services and diagnostics. Founded in 1967, the company has expanded its operations across Europe, Africa, and the Middle East, establishing a strong presence in the medical testing industry. With a commitment to innovation, Cerba Healthcare offers a comprehensive range of services, including clinical pathology, genetic testing, and specialised diagnostics. Their unique approach combines advanced technology with a patient-centric focus, ensuring high-quality results and rapid turnaround times. Recognised for its excellence, Cerba Healthcare has achieved significant milestones, positioning itself as a trusted partner for healthcare professionals and institutions. The company’s dedication to precision and reliability has solidified its reputation as a leader in the laboratory services market.
DitchCarbon Score
How does Cerba Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cerba Healthcare's score of 31 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cerba Healthcare's reported carbon emissions
In 2023, Cerba Healthcare reported total carbon emissions of approximately 339,011,000 kg CO2e. This figure includes 12,879,000 kg CO2e from Scope 1 emissions, 6,131,000 kg CO2e from Scope 2, and a significant 320,000,000 kg CO2e from Scope 3 emissions, which primarily stem from purchased goods and services (124,800,000 kg CO2e) and upstream transportation and distribution (137,600,000 kg CO2e). Cerba Healthcare has set ambitious climate commitments, aiming for a 42% reduction in CO2 emissions for Scopes 1 and 2 by 2030, compared to 2021 levels. This target reflects a proactive approach to mitigating their environmental impact and aligns with industry standards for climate action. The company is on track to achieve this reduction, demonstrating a commitment to sustainability and responsible business practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 7,730,000 | 000,000 | 00,000,000 |
| Scope 2 | 4,091,000 | - | 0,000,000 |
| Scope 3 | 677,284,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cerba Healthcare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
